eDHR for Medical Devices: QMSR, Part 11 & Digital Manufacturing (2026)

eDHR implementation guide for medical device manufacturers: QMSR requirements, 21 CFR Part 11, MES integration, ISO 13485, paper-to-digital migration, and inspection readiness.

The Paper Problem That Has Defined Device Manufacturing

For decades, medical device manufacturing has run on paper. Paper travelers tracking each unit through production steps. Paper test sheets recording inspection results. Paper labels verified by human eyes. Paper signatures confirming that operators completed their tasks. Rooms of filing cabinets storing device history records that regulators might request at any time.

The device history record (DHR) is one of the most fundamental documents in medical device manufacturing. It is the complete production record for every batch or unit — proof that the device was built according to its specifications, that materials were correct, that processes were followed, that tests were passed, and that trained personnel performed each step. Under the old Quality System Regulation, 21 CFR 820.184 required manufacturers to prepare and maintain a DHR for each batch or lot that included the date of manufacture, the quantity manufactured, the quantity released, acceptance records, primary identification labels, and any device identification or control numbers used.

That requirement has not gone away. What has changed is everything around it. The Quality Management System Regulation (QMSR), effective February 2, 2026, replaced the QSR and incorporated ISO 13485:2016 by reference into 21 CFR Part 820. ISO 13485:2016 Section 7.5.1 requires documented information for manufacturing processes — the functional equivalent of DHR requirements, expressed in the language of "control of production and service provision" and "documented information." The FDA's inspection approach transitioned from the Quality System Inspection Technique (QSIT) to a QMSR-aligned methodology on the same date. Industry 4.0 is accelerating: the market for smart manufacturing technologies is projected to grow from $239 billion in 2026 to $801 billion by 2034. And the digital thread — the concept of linking design data, production records, quality documentation, and supplier information into a single, traceable, connected data flow — has moved from aspiration to baseline expectation.

This is the context in which electronic Device History Records (eDHR) have become not just a nice-to-have efficiency improvement, but a strategic imperative. This guide covers what eDHR is, how it fits into the regulatory frameworks that govern medical device manufacturing, what it takes to implement one, and how to prepare for the FDA and Notified Body inspections that will evaluate it.

What Is an eDHR and How Does It Differ from Paper?

An electronic Device History Record (eDHR) replaces the paper traveler, test sheets, logbooks, and signature blocks that have traditionally comprised the DHR with a structured electronic record. It captures the same information that a paper DHR must contain — production data, material traceability, test and inspection results, label verification, quality events, and operator signatures — but in a digital system that enforces compliance rules in real time.

The distinction is not merely about digitizing paper. A well-implemented eDHR system is fundamentally different from a scanned copy of a paper traveler. The key differences:

Enforced workflows — The system prevents operators from skipping steps, using unapproved materials, or proceeding without completed training. Paper relies on human discipline; eDHR relies on system logic.
Real-time error-proofing — The system flags deviations, out-of-specification results, and missing data at the point of entry, not days later during batch record review.
Immediate traceability — Material lot numbers, equipment used, operator identity, and process parameters are captured electronically and linked to each unit or batch. Searching a paper DHR for a specific lot of raw material might take hours; an eDHR can produce the answer in seconds.
Electronic signatures — Instead of initials on a paper form, operators apply 21 CFR Part 11-compliant electronic signatures that include the signer's name, the date and time, the meaning of the signature (e.g., "performed by," "verified by," "approved by"), and an audit trail that records any subsequent changes.
Connected data — The eDHR does not exist in isolation. It integrates with Manufacturing Execution Systems (MES), Quality Management Systems (QMS), Laboratory Information Management Systems (LIMS), Enterprise Resource Planning (ERP) systems, labeling systems, UDI repositories, and supplier management platforms.

These differences translate directly into operational outcomes. eDHR enables faster product release because batch record review is not dependent on manually checking paper forms. It supports immediate batch identification for quality events — when a nonconformance or complaint is received, the system can instantly identify every device produced using the same material lot, equipment, or operator. And it makes limited field recalls feasible by enabling precise traceability rather than broad lot-level recalls.

QMSR and ISO 13485 Requirements for Device History Records

The Regulatory Basis Under QMSR

The QMSR, effective February 2, 2026, fundamentally changed how the FDA approaches quality system requirements for medical devices. Rather than maintaining its own set of prescriptive requirements in 21 CFR 820, the FDA incorporated ISO 13485:2016 by reference. This means the ISO 13485 standard text is now the primary source of quality system requirements for FDA-regulated device manufacturers, supplemented by FDA-specific additions that the agency retained.

For device history records specifically, the relevant ISO 13485:2016 requirements are:

Clause 7.5.1 — Control of production and service provision. This clause requires organizations to plan, carry out, control, and monitor production processes under controlled conditions. These conditions include the availability of documented information describing product characteristics, the availability of documented information defining the activities to be performed and the results to be achieved, monitoring activities, and the availability and use of suitable monitoring and measuring resources. The documented information required under this clause is the functional equivalent of the DHR.

Clause 7.5.2 — Cleanliness of product. Where product cleanliness is a requirement, documented information must specify the cleanliness requirements.

Clause 7.5.3 — Installation activities. Where installation is a specified activity, documented information must describe the installation and verification requirements.

Clause 7.5.6 — Validation of processes for production and service provision. Processes whose output cannot be verified by subsequent monitoring or measurement must be validated, and the results of this validation constitute part of the production record.

Clause 7.5.9 — Traceability. This is the traceability clause, which requires organizations to document the traceability requirements and the records to be maintained. For implantable devices, the organization must record the identity of all components and materials, the conditions and work environment, and the persons performing any production step.

Clause 7.5 — Control of documented information (general). ISO 13485:2016 requires organizations to control documented information, ensuring it is available and suitable for use, adequately protected, and retained for the required periods.

What This Means for eDHR

The QMSR's incorporation of ISO 13485 does not change the substance of what a device history record must contain. It changes the regulatory language and the audit framework. Under the old QSR, FDA inspectors used QSIT (Quality System Inspection Technique) to evaluate DHR compliance. Under QMSR, the inspection approach aligns with ISO 13485's structure and the process-based auditing methodology that Notified Bodies have used for years.

For eDHR implementation, the practical implications are:

Documented information requirements are explicit. ISO 13485 uses the term "documented information" throughout, and the standard makes clear that this includes both the procedures governing production and the records generated during production. Your eDHR system must be designed to capture, control, and retain all required documented information.
Traceability requirements are arguably more specific. ISO 13485 Clause 7.5.9 is more detailed than the old 820.184 regarding what traceability records must include — particularly for implantable devices. Your eDHR must support full component and material traceability, equipment traceability, operator traceability, and environmental condition recording where required.
Risk-based approach is embedded. ISO 13485 requires a risk-based approach throughout the quality management system, including production and service provision. This means your eDHR system should be designed with risk in mind — controlling the steps and data that have the greatest impact on product quality and patient safety, and applying appropriate rigor based on risk.
The FDA-specific additions still apply. The QMSR retains certain FDA-specific requirements, including complaint file requirements, MDR reporting integration, corrections and removals, and record retention periods. Your eDHR system must accommodate these US-specific requirements alongside the ISO 13485 baseline.

21 CFR Part 11 Compliance for Electronic Manufacturing Records

Any medical device manufacturer that uses an electronic system to create, modify, maintain, archive, retrieve, or transmit device history records must comply with 21 CFR Part 11. This is not a discretionary requirement. The FDA considers electronic records that meet Part 11 requirements to be equivalent to paper records and handwritten signatures. If you choose to use electronic records, Part 11 applies.

Core Part 11 Requirements for eDHR Systems

The Part 11 requirements that are most directly relevant to eDHR systems include the following.

System validation (11.10(a)). The eDHR system must be validated to ensure it performs its intended functions accurately and reliably. This means documented evidence that the system captures all required production data, enforces workflow rules, applies electronic signatures correctly, maintains audit trails, and produces accurate and complete copies of records. Validation must follow a lifecycle approach — installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) — with documented evidence at each stage.

Accurate and complete copies (11.10(b)). The system must be able to generate accurate and complete copies of eDHR records in both human-readable and electronic form suitable for FDA inspection, review, and copying. This means your system must be able to export or print complete batch records including all data, metadata, audit trail entries, and electronic signature manifestations.

Record protection and retention (11.10(c)). eDHR records must be protected to enable their accurate and ready retrieval throughout the records retention period. The FDA generally requires device history records to be retained for the design life of the device, but no less than two years from the date of release. Your system must support backup, disaster recovery, archival, and migration procedures that ensure record integrity over these retention periods.

Access controls (11.10(d)). System access must be limited to authorized individuals. This requires unique user IDs, role-based access controls, password policies, periodic access reviews, and procedures for revoking access when personnel change roles or leave the organization.

Audit trail (11.10(e)). This is one of the most critical and frequently inspected Part 11 requirements. The eDHR system must use secure, computer-generated, time-stamped audit trails that independently record the date and time of operator entries and actions that create, modify, or delete electronic records. The audit trail must capture the old value, new value, who made the change, when, and why. It must not allow operators to modify or disable it. It must be available for review and copying by the FDA. And it must be retained for the same duration as the electronic record itself.

Operational system checks (11.10(f)). The system must enforce sequencing of steps and events. In an eDHR context, this means the system must prevent operators from proceeding to a manufacturing step before prerequisites are completed — for example, preventing a label application step before label verification has been completed, or preventing final release before all in-process inspections are passed.

Authority checks (11.10(g)). The system must enforce that only authorized individuals can perform specific operations. This means the eDHR system must enforce training record currency (operators cannot perform a step for which they have not been trained), equipment qualification (production steps cannot be performed on equipment that is not qualified), and correct material usage (only approved materials with passing inspection results can be used in production).

Electronic signatures (11.50, 11.70). Each electronic signature must be unique to one individual and not be reused by or reassigned to anyone else. The signed electronic record must contain information associated with the signing that clearly indicates the signer's name, the date and time, and the meaning of the signature. Electronic signatures must be linked to their respective electronic records and must not be separated from them.

Open vs. Closed Systems

Most eDHR systems operate as closed systems — environments in which system access is controlled by the people responsible for the content of the electronic records. If your eDHR system is cloud-based and accessed over the internet by authorized employees, it is still a closed system as long as the people responsible for the records control access.

An open system would be one where access is not controlled by the people responsible for the records — for example, a web portal that allows suppliers to directly enter material certification data into your eDHR system. Open systems require additional controls under Part 11, including encryption and digital signatures, to ensure record authenticity and integrity.

eDHR Enforcement Rules Under Part 11

A compliant eDHR system must enforce the following production rules as system-level controls, not just procedural requirements:

Training record currency — The system must verify that the operator has completed all required training before allowing them to perform a manufacturing step. If training has expired or was never completed, the system must block the step.
Equipment qualification — The system must verify that the equipment assigned to a production step is within its qualification period. If equipment qualification has lapsed, the system must prevent its use.
Correct material usage — The system must verify that the materials being used are approved for the specific device and production step, that they have passed incoming inspection, and that they are within their shelf life.
Complete data capture — The system must require that all mandatory data fields are completed before a step can be signed off. Incomplete records must be flagged and the step held open.
Electronic signatures with meaning — Each signature must include the meaning of the signature (e.g., "performed by," "verified by," "approved by"), and the system must enforce that the appropriate type of signature is applied at each step.

EU MDR Requirements for Manufacturing Documentation

Article 10 and Technical Documentation

The EU Medical Device Regulation (EU 2017/745) requires manufacturers to maintain comprehensive documentation of their devices and manufacturing processes. Article 10(4) requires manufacturers to establish, document, implement, and maintain a quality management system that ensures compliance with the regulation. This quality management system must address, among other things, manufacturing processes and their control.

Annex IX of the EU MDR sets out the conformity assessment procedures based on a quality management system and assessment of technical documentation. The technical documentation requirements include manufacturing process documentation — specifically, information on the design, manufacture, and performance of the device, including manufacturing process flow charts, quality control measures, and process validation documentation.

Data Integrity Under EU MDR

The EU MDR requires that electronic systems used for compliance activities meet data integrity standards. This means that eDHR systems used by manufacturers selling in the EU must ensure that manufacturing records are attributable, legible, contemporaneous, original, and accurate — the ALCOA principles that govern data integrity in regulated industries.

While the EU MDR does not reference 21 CFR Part 11 directly (Part 11 is a US regulation), the same functional requirements apply. EU Notified Bodies expect electronic manufacturing record systems to have validated access controls, audit trails, electronic signature controls, and data protection measures that are equivalent to what Part 11 requires.

ISO 13485 as the Harmonized Standard

ISO 13485:2016 is the harmonized standard under the EU MDR for quality management systems. This means that for EU market access, the same ISO 13485 requirements described above — Clause 7.5.1 on production control, Clause 7.5.9 on traceability, and Clause 7.5 on control of documented information — apply to EU-based manufacturing operations. A well-designed eDHR system can serve both US and EU regulatory requirements simultaneously.

Practical Implications for Dual-Market Manufacturers

For manufacturers selling in both the US and the EU, the convergence of requirements is a significant advantage. The QMSR's incorporation of ISO 13485 means that the same quality management system — and the same eDHR system — can serve both markets. The key is to ensure that the system accommodates both the FDA-specific additions retained under QMSR (complaint file requirements, MDR reporting integration, record retention periods) and the EU MDR-specific requirements (technical documentation, CE marking records, post-market surveillance documentation).

The Digital Thread: Connecting DHF, DMR, and eDHR

The digital thread is the concept of creating a continuous, connected data flow from initial design through manufacturing, distribution, and post-market surveillance. For medical device manufacturers, the digital thread connects three critical sets of records:

DHF (Design History File) — The compilation of records describing the design history of a device, including design inputs, outputs, reviews, verification, validation, and changes.
DMR (Device Master Record) — The compilation of specifications and procedures for a device, including device specifications, production process specifications, quality assurance procedures, packaging and labeling specifications, and DHR requirements.
DHR (Device History Record) — The production record for each batch or unit, demonstrating that the device was manufactured in accordance with the DMR.

In a paper-based system, these three records exist in separate document repositories with no automated connection between them. A design change recorded in the DHF must be manually propagated to the DMR and then to the DHR. This manual propagation is slow, error-prone, and difficult to audit.

The digital thread changes this. When the eDHR is integrated with the electronic DMR and the electronic DHF, the following connections become automated:

Design change propagation — When a design change is approved in the DHF, the updated specifications automatically flow to the DMR, and the eDHR system immediately begins enforcing the new requirements on the production floor.
Specification enforcement — The eDHR system verifies that production data falls within the specifications defined in the DMR, flagging any deviations in real time.
Feedback loops — Production data captured in the eDHR feeds back into quality monitoring, complaint handling, and post-market surveillance systems. Nonconformance data from manufacturing can trigger CAPA investigations, which may lead to design changes documented in the DHF.
Traceability — The complete history of any device can be traced from its design intent (DHF) through its manufacturing specifications (DMR) to its actual production record (eDHR) and onward to any complaints, adverse events, or corrective actions.

NIST's digital thread initiative has promoted this connected approach as a foundation for advanced manufacturing. The concept aligns directly with the quality system principles in ISO 13485, which requires organizations to establish processes for determining, collecting, and analyzing appropriate data to demonstrate the suitability, adequacy, and effectiveness of the quality management system.

The connected quality system extends this thread beyond manufacturing. When eDHR data is linked to CAPA, complaint handling, and post-market surveillance systems, the manufacturer gains the ability to identify trends, detect emerging quality issues, and respond to safety signals with speed and precision that paper-based systems cannot match.

MES Integration and Connected Quality Systems

The Role of Manufacturing Execution Systems

A Manufacturing Execution System (MES) is the software layer that sits between the enterprise planning level (ERP) and the shop floor control level. In medical device manufacturing, the MES manages the execution of production processes — issuing work orders, tracking materials and work-in-progress, capturing production data, enforcing process sequences, and recording results.

The eDHR is not the MES, but they are closely related. In many implementations, the eDHR functionality is embedded within the MES. The MES executes the production process and generates the electronic records that constitute the eDHR. In other implementations, the eDHR is a separate application that receives data from the MES and other systems.

Integration Points

The eDHR integrates with multiple enterprise systems to create a connected quality and manufacturing environment:

System	Integration Function
QMS	Nonconformance reports (NCRs), CAPAs, and change controls linked to production records; complaint data feeding back to manufacturing
LIMS	Test results and laboratory data automatically populated in eDHR; sample tracking and stability data
ERP	Material master data, inventory management, bill of materials, work order management feeding into eDHR
Labeling systems	Label content verification, UDI assignment, label print records captured in eDHR
Supplier management	Supplier certificates of analysis, incoming inspection results, and material traceability linked to production records
Training management	Training records and competency assessments verified before operator assignment to production steps
Equipment management	Equipment qualification status, calibration records, and maintenance logs verified before equipment use

Real-Time Visibility and Error-Proofing

The primary operational benefit of integrated eDHR is real-time visibility into manufacturing operations and error-proofing at the point of execution. In a paper system, errors are typically discovered during batch record review — which may be days or weeks after production. In an eDHR system, errors are caught and prevented at the point of data entry.

Examples of real-time error-proofing include:

Barcode scanning of material lot numbers to verify correct materials before use, with the system rejecting incorrect or expired materials
Automatic recording of equipment parameters (temperature, pressure, time) from connected instruments, eliminating manual data entry errors
System-enforced sampling plans that require the correct number of samples to be tested before proceeding
Label verification using vision systems that compare applied labels to approved label artwork
Training verification that prevents untrained operators from performing critical steps

These capabilities directly support the quality objectives of ISO 13485 and the QMSR: ensuring that processes are carried out under controlled conditions, that product conformity is verified at appropriate stages, and that traceability is maintained throughout production.

Paper-to-Digital Migration Strategy and Validation

Migration Planning

Transitioning from paper DHR to eDHR is a significant project that touches procedures, training, systems, validation, and regulatory records. A structured approach is essential.

Phase 1: Assessment and planning. Begin with a thorough assessment of your current paper DHR processes. Document every form, every signature point, every data entry point, and every review step. Map these to the requirements in ISO 13485 Clause 7.5.1 and 21 CFR Part 11. Identify gaps between your current paper process and the capabilities you need in the eDHR system. Define the scope of the migration — will you convert all products simultaneously, or phase the rollout by product line or manufacturing site?

Phase 2: System selection and design. Select an eDHR platform that meets your regulatory requirements (Part 11 compliance, ISO 13485 alignment, data integrity) and your operational requirements (MES integration, scalability, user experience). Design the eDHR workflows to match your manufacturing processes, with appropriate system-enforced controls at each step.

Phase 3: System validation. Validate the eDHR system in accordance with 21 CFR Part 11 requirements and ISO 13485 Clause 4.1.6 (which addresses computer software used in the quality management system). Validation must include:

Installation Qualification (IQ) — Verifying that the system is installed correctly in its operating environment
Operational Qualification (OQ) — Testing each system function against its specifications, including workflow enforcement, data capture, electronic signatures, audit trails, and access controls
Performance Qualification (PQ) — Demonstrating that the system performs reliably under actual or simulated production conditions over a defined period

Phase 4: Data migration. If you need to migrate historical paper DHR records into the electronic system, develop a migration protocol that ensures data integrity. This includes defining which historical records will be migrated, verifying the accuracy of migrated data, and maintaining the original paper records for the required retention period.

Phase 5: Training and go-live. Train all affected personnel — operators, supervisors, quality engineers, and management — on the new eDHR system. Training must cover system operation, electronic signature procedures, deviation handling, and the differences from the previous paper process. Consider a parallel run period where both paper and electronic records are maintained to build confidence and identify issues before full cutover.

Phase 6: Hypercare and optimization. After go-live, provide intensive support to address issues quickly. Monitor system performance, user adoption, and data quality. Collect feedback from operators and quality staff to identify workflow improvements.

Validation Considerations Specific to eDHR

Validation of an eDHR system requires particular attention to several areas:

Workflow enforcement testing — Verify that the system correctly enforces the defined manufacturing sequence and prevents out-of-sequence operations. Test boundary conditions: what happens when a step is skipped, when invalid data is entered, when an untrained operator attempts a task?
Electronic signature testing — Verify that electronic signatures are applied correctly, that they capture the required information (signer identity, date/time, meaning), that they are linked to the signed record, and that they cannot be separated from the record.
Audit trail testing — Verify that the audit trail captures all create, modify, and delete operations; that it captures old values, new values, the identity of the person making the change, and the reason; and that the audit trail cannot be modified or disabled by operators.
Data integrity testing — Verify that data is captured accurately, stored securely, retrieved completely, and exported in formats suitable for regulatory inspection.
Integration testing — Verify that data flows correctly between the eDHR system and connected systems (MES, QMS, ERP, LIMS). Test error handling for integration failures.
Disaster recovery and business continuity — Verify that backup and restore procedures work correctly, that records can be recovered after a system failure, and that business continuity plans are effective.

Risk-Based Approach to Validation

ISO 13485's risk-based approach applies to system validation as well. Not every system function requires the same depth of testing. Functions that directly affect product quality and patient safety — such as workflow enforcement, material verification, test result capture, and electronic signatures — require more rigorous testing than administrative functions. Use risk assessment to prioritize validation effort where it matters most.

FDA Inspection Readiness with eDHR Under QMSR

The New Inspection Landscape

As of February 2, 2026, FDA inspections of medical device manufacturers are conducted under the QMSR framework rather than the old QSIT methodology. This means inspectors evaluate quality systems against ISO 13485's process-based structure, supplemented by the FDA-specific additions retained in 21 CFR 820.

For eDHR, this has several implications:

Inspectors will evaluate production controls as a process. Rather than checking a DHR against a specific list of QSR requirements, inspectors will evaluate whether your production processes are planned, controlled, monitored, and documented in accordance with ISO 13485 Clause 7.5. The eDHR is the primary evidence of this control.
Part 11 compliance will be evaluated. If you use electronic records for your DHR, FDA inspectors will evaluate whether those records meet Part 11 requirements. This includes reviewing validation documentation, audit trail functionality, electronic signature controls, and access controls.
Traceability will be tested. Inspectors may select a device and trace its complete manufacturing history — from raw materials through production steps to finished device release. Your eDHR system must be able to produce this traceability information quickly and completely.
Connected quality data will be examined. Inspectors may follow the trail from a production record to a nonconformance report, a CAPA, or a complaint. Your eDHR system must support these linkages.

Preparing for Inspection

Key preparation steps for FDA inspection readiness with eDHR:

Maintain current validation documentation. Ensure that your eDHR system validation documentation is complete, current, and readily accessible. This includes the validation plan, IQ/OQ/PQ protocols and reports, traceability matrices, and any change control records for system modifications.
Conduct mock inspections. Perform internal audits that simulate FDA inspection techniques. Select devices and trace their complete manufacturing history through the eDHR system. Verify that audit trails are functioning, electronic signatures are compliant, and records can be produced in human-readable form.
Train personnel. Ensure that operators, supervisors, and quality staff can demonstrate competence with the eDHR system. Inspectors will ask operators to show how they perform their tasks, how they apply electronic signatures, and how they handle deviations.
Verify record retrieval capabilities. Practice retrieving eDHR records in response to typical inspection requests: batch records for a specific lot, all devices manufactured with a specific material lot, all production records for a specific date range, and records of changes made to a specific batch record.
Review Part 11 compliance. Conduct a Part 11 self-assessment covering system validation, audit trail functionality, electronic signature controls, access controls, record protection, and backup/recovery procedures.

Industry 4.0 and the Future of Medical Device Manufacturing

The Digital Manufacturing Landscape in 2026

The manufacturing landscape in 2026 is shaped by several converging trends. The Industry 4.0 market — encompassing IoT, AI, robotics, and digital manufacturing technologies — is projected to grow from $239 billion in 2026 to $801 billion by 2034. Key trends identified by industry observers include:

Digital thread as a baseline requirement. The expectation that manufacturing data will flow continuously from design through production to post-market is no longer aspirational — it is becoming a baseline requirement for competitive manufacturing operations.
Embedded AI in manufacturing. AI is being integrated into manufacturing execution systems for predictive quality, anomaly detection, predictive maintenance, and process optimization. In an eDHR context, AI can identify patterns in production data that indicate emerging quality issues before they result in nonconformances.
Digitally fluent workforce. The workforce expectation is shifting from operators who follow paper instructions to operators who interact with digital systems, interpret real-time data, and make informed decisions based on system-generated insights.
Reshoring and supply chain digitization. The trend toward reshoring manufacturing operations is driving investment in digital manufacturing infrastructure, including eDHR systems that can be rapidly deployed at new production sites.

Connected Quality and Post-Market Surveillance

The eDHR is increasingly part of a connected quality ecosystem that links manufacturing data to post-market surveillance. When eDHR data is connected to complaint handling, CAPA, and post-market surveillance systems, manufacturers gain the ability to:

Identify production-related root causes of complaints more quickly
Detect trends in field performance that correlate with specific production batches, materials, or equipment
Target recalls more precisely by identifying the specific devices affected by a manufacturing issue
Provide regulators with comprehensive, data-driven responses to safety inquiries

This connected approach aligns with the QMSR's emphasis on a process-based quality management system and ISO 13485's requirements for analysis of data and feedback.

Key Challenges and How to Address Them

System Validation

Challenge. Validating an eDHR system is a substantial undertaking. The system must be validated in accordance with 21 CFR Part 11 and ISO 13485, and validation must cover workflow enforcement, electronic signatures, audit trails, data integrity, integration with other systems, and disaster recovery.

How to address it. Use a risk-based approach to validation, prioritizing testing of functions that directly affect product quality and patient safety. Leverage vendor-provided validation documentation where appropriate (particularly for cloud-based eDHR platforms), but supplement it with your own testing to confirm that the system operates correctly in your specific environment and configuration. Maintain a validation summary that is inspection-ready at all times.

Data Migration

Challenge. Migrating historical paper DHR records to an electronic system raises questions about data integrity, completeness, and regulatory equivalence.

How to address it. Develop a formal data migration protocol. Define which historical records will be migrated and which will remain in paper form (typically, records beyond their retention period can be archived or destroyed per your record retention policy). For records that are migrated, verify accuracy by comparing a sample of migrated records against the originals. Maintain the original paper records for the required retention period, regardless of migration status. Document the migration process, including the migration protocol, verification results, and any discrepancies identified and resolved.

Operator Training and Change Management

Challenge. Moving from paper to electronic records is a significant change for manufacturing operators who may be accustomed to paper-based workflows. Resistance to change, unfamiliarity with digital systems, and the learning curve associated with new procedures can slow adoption and introduce errors.

How to address it. Invest in comprehensive, hands-on training that allows operators to practice with the eDHR system before go-live. Use a training environment that mirrors the production system. Involve operators in the system design process — they understand the practical realities of the production floor and can provide valuable input on workflow design. Implement a phased rollout that allows operators to build confidence gradually. Provide readily accessible support during the transition period.

Paper-to-Digital Transition Management

Challenge. During the transition period, some products or production lines may be on paper DHR while others are on eDHR. This hybrid state creates complexity for quality oversight, training, and inspection readiness.

How to address it. Define clear criteria for which products or lines convert to eDHR and when. Maintain a transition plan that specifies the timeline, responsibilities, and criteria for each conversion. During the hybrid period, ensure that quality oversight covers both paper and electronic records, and that personnel are trained on the appropriate procedures for each system. Minimize the duration of the hybrid state by planning conversions in rapid, manageable phases rather than a prolonged, drawn-out process.

Maintaining Compliance During System Changes

Challenge. eDHR systems require ongoing maintenance, updates, and configuration changes. Each change must be managed through a controlled change management process to maintain the validated state of the system.

How to address it. Implement a formal change management process for all eDHR system changes. Assess the impact of each change on the validated state. Perform revalidation testing appropriate to the scope and risk of the change. Document all changes, testing, and results. Maintain a current validation state summary that reflects the cumulative effect of all changes since the original validation.

Closing Perspective

The shift from paper to electronic device history records is not a question of if, but when and how. The regulatory environment under QMSR, the enforcement expectations of 21 CFR Part 11, the requirements of ISO 13485 and the EU MDR, and the operational demands of Industry 4.0 all converge on the same conclusion: digital manufacturing records are the future of medical device manufacturing.

The companies that will navigate this transition most effectively are those that approach it as a strategic initiative — not just an IT project, but a transformation of how manufacturing quality is documented, controlled, and demonstrated. This means investing in the right technology, the right validation approach, and the right change management to ensure that operators, quality staff, and management are aligned around the benefits and requirements of electronic manufacturing records.

The regulatory frameworks are aligned. The technology is mature. The business case is clear. The remaining variable is execution.